Akshya Lifesciences has proposed a new pharmaceutical manufacturing unit at Plot No 1K, EPIP Phase I, Jharmajri Industrial Area, Tehsil Baddi, District Solan, Himachal Pradesh, with an estimated project cost of Rs. 83.504 Million, comprising land cost of Rs. 8.970 Million, building cost of Rs. 4.995 Million, plant and machinery worth Rs. 59.302 Million, and other fixed assets of Rs. 10.237 Million. The facility is designed to manufacture a diversified basket of pharmaceutical formulations including tablets (700 Million Numbers), capsules (175 Million Numbers), dry syrup (80 Million Numbers), syrup liquid (90 Million Numbers), and ointment (30 Million Numbers) annually. The unit is expected to generate employment for around 40 people and will be set up on 1375 Sq. Mtr. of government land. Typical machinery and equipment for such a facility would likely include tablet compression machines, capsule filling machines, blending and granulation equipment, liquid and syrup filling lines, ointment manufacturing and filling units, along with quality control laboratory instruments and packaging lines. The State Pollution Control Board has granted Consent to Establish for the project. On June 2026, State Review Committee has approved the investment proposal. As of September 2026, the project work has commenced.